申请人:Merck Sharp & Dohme Ltd.
公开号:US05760018A1
公开(公告)日:1998-06-02
The present invention is directed to certain compounds represented by structural formula I: ##STR1## or a pharmaceutically acceptable salt thereof wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, A.sup.1, A.sup.2, X, m and n are defined herein. The compounds of this invention are tachykinin receptor antagonists and are of particular use in the treatment of pain, inflammation, migraine and emesis.
本发明涉及由结构式I表示的特定化合物:##STR1##或其药学上可接受的盐,其中R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5、R.sup.6、R.sup.7、A.sup.1、A.sup.2、X、m和n在此处定义。本发明的化合物是催吐肽受体拮抗剂,特别适用于治疗疼痛、炎症、偏头痛和呕吐。